Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar depression. It works by modulating dopamine and serotonin receptors, which helps stabilize mood and reduce hallucinations or delusions. It has a relatively lower risk of metabolic side effects compared to other antipsychotics.